Curcumin Nanoparticles and Their Cytotoxicity in Docetaxel-Resistant Castration-Resistant Prostate Cancer Cells

Most prostate cancer patients develop resistance to anti-androgen therapy. This is referred to as castration-resistant prostate cancer (CRPC). Docetaxel (DTX) is the mainstay treatment against CRPC. However, over time patients eventually develop DTX resistance, which is the cause of the cancer-relat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaudommongkon, Irin, Tanaudommongkon, Asama, Prathipati, Priyanka, Nguyen, Joey Trieu, Keller, Evan T., Dong, Xiaowei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459888/
https://www.ncbi.nlm.nih.gov/pubmed/32751450
http://dx.doi.org/10.3390/biomedicines8080253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459888/
https://www.ncbi.nlm.nih.gov/pubmed/32751450
http://dx.doi.org/10.3390/biomedicines8080253

Ejemplares similares